Polymethoxylated flavones in orange juice are inhibitors of P- glycoprotein but not cytochrome P450 3A4

Journal of Pharmacology and Experimental Therapeutics

Volumn 293, Issue 1, 2000, Pages 230-236

  Takanaga, Hitomi ^a   Ohnishi, Ayako ^a   Yamada, Shiho ^a   Matsuo, Hirotami ^a   Morimoto, Satoshi ^a   Shoyama, Yukihiro ^a   Ohtani, Hisakazu ^a   Sawada, Yasufumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; CYTOCHROME P450 3A4; FLAVONE DERIVATIVE; GLYCOPROTEIN P; NOBILETIN; TANGERETIN; VINBLASTINE;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG IDENTIFICATION; DRUG INHIBITION; DRUG ISOLATION; DRUG POTENCY; DRUG STRUCTURE; DRUG TRANSPORT; DRUG UPTAKE; FRUIT JUICE; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BEVERAGES; CACO-2 CELLS; CELL SURVIVAL; CITRUS; CYCLOSPORINE; CYTOCHROME P-450 ENZYME SYSTEM; FLAVONES; FLAVONOIDS; HUMANS; HYDROXYLATION; LIVER; LLC-PK1 CELLS; MIXED FUNCTION OXYGENASES; P-GLYCOPROTEIN; SOLVENTS; SWINE; TESTOSTERONE; VINBLASTINE;

EID: 0034029597     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Ameer B and Weintraub RA (1997) Drug interactions with grapefruit juice. Clin Pharmacokinet 33:103-121.
2. Bailey DG, Malcolm J, Arnold O and Spence JD (1998) Grapefruit juice-drug interaction. Br J Clin Pharmacol 46:101-110.
3. Buening MK, Chang RL, Huang M-T, Fortner JG, Wood AW and Conney AH (1981) Activation and inhibition of benzo(a)pyrene and aflatoxin B1 metabolism in human liver microsomes by naturally occurring flavonoid. Cancer Res 41:67-72.
4. Canivenc-Lavier M-C, Bentejac M, Moller M-L, Leclerc J, Siess M-H, Latruffe N and Suschetet M (1996) Differential effects of nonhydroxylated flavonoids as inducers of cytochrome P450 1A and 2B isozymes in rat liver. Toxicol Appl Pharmacol 136:348-353.
5. Chaumontet C, Droumaguet C, Bex V, Heberden C, Gaillard-Sanchez I and Martel P (1997) Flavonoids (apigenin, tangeretin) counteract tumor promoter-induced inhibition of intercellular communication of rat liver epithelial cells. Cancer Lett 114:207-210.
6. Chun Y-T and Sankawa U (1989) Screening of antiallergic effect in traditional medicinal drugs and active constituents of Aurantii Fructus Immaturus. Shoyakugaku Zasshi 43:314-323.
7. Edwards DJ, Bellevue FH and Woster PM (1996) Identification of 6′,7′-dihydroxybergamottin, a cytochrome P450 inhibitor, in grapefruit juice. Drug Metab Dispos 24:1287-1290.
8. Edwards DJ and Bernier SM (1996) Naringin and naringenin are not the primary CYP3A inhibitors in grapefruit juice. Life Sci 59:1025-1030.
9. Fuhr U, Anders EM, Mahr G, Sorgel F and Staib AH (1992) Inhibitory potency of quinolone antibacterial agents against cytochrome P450IA1 in vivo and in vitro. Antimicrob Agents Chemother 36:942-948.
10. Guengerich FP and Kim DH (1990) In vitro inhibition of dihydropyridine oxidation and aflatoxin B1 activation in human liver microsomes by naringenin and other flavonoids. Carcinogenesis 11:2275-2279.
11. Herrmann K (1988) On the occurrence of flavonol and flavone glycosides in vegetables. Z Lebensm Unters Forsch 186:1-5.
12. Kiuchi Y, Suzuki H, Hirohashi T, Tyson CA and Sugiyama Y (1998) cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3). FEBS Lett 433:149-152.
13. Lang CC, Brown RM, Kinirons MT, Deathridge MA, Guengerich FP, Kelleher D, O'Briain DS, Ghishan FK and Wood AJ (1996) Decreased intestinal CYP3A in celiac disease: Reversal after successful gluten-free diet: A potential source of interindividual variability in first-pass drug metabolism. Clin Pharmacol Ther 59:41-46.
14. Lasker JM, Huang MT and Conney AH (1984) In vitro and in vivo activation of oxidative drug metabolism by flavonoids. J Pharmacol Exp Ther 229:162-170.
15. Lown KS, Bailey DG, Fontana RJ, Janardan SK, Adair CH, Fortage LA, Brown MB, Guo W and Watkins PB (1997) Grapefruit juice increases felodipine oral availability in human by decreasing intestinal CYP3A protein expression. J Clin Invest 99:2545-2553.
16. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
17. Machida K and Osawa K (1989) On the flavonoid constituents from the peels of Citrus hassaku HORT, ex Tanaka. Chem Pharm Bull 37:1092-1094.
18. Mays DC, Camisa C, Cheney P, Pacula CM, Nawoot S and Gerber N (1987) Methoxsalen is a potent inhibitor of the metabolism of caffeine in humans. Clin Pharmacol Ther 39:265-270.
19. Middleton E and Kandaswami C (1992) Effects of flavonoids on immune and inflammatory cell functions. Biochem Pharmacol 43:1167-1179.
20. Miniscalco A, Lundahl J, Regardh CG, Edger B and Eriksson UG (1992) Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice. J Pharmacol Exp Ther 261:1195-1199.
21. Mouly P, Gaydou EM and Auffray A (1998) Simultaneous separation of flavanone glycosides and polymethoxylated flavones in citrus juices using liquid chromatography. J Chromatogr A 800:171-179.
22. Mukhtar H, Das M, Khan WA, Wang ZY, Bik DP and Bickers DR (1988) Exceptional activity of tannic acid among naturally occurring plant phenols in protecting against 7,12-dimethylbenz(a) anthracene-, benzo(a)pyrene-, 3-methylcholanthrene-, and N-methyl-N-nitrosourea-induced skin tumorigenesis in mice. Cancer Res 48:2361-2365.
23. Nelson EK (1934) The occurrence of a pentamethyl flavonol in tangerine peel. J Am Chem Soc 56:1392.
24. Obermeier MT, White RE and Yang CS (1995) Effects of bioflavonoids on hepatic P450 activities. Xinobiotica 25:575-584.
25. Okey AB (1990) Enzyme induction in the cytochrome P-450 system. Pharmacol Ther 45:241-298.
26. Satoh Y, Tashiro S, Satoh M, Fujimoto Y, Xu J-Y and Ikekawa T (1996) Studies on the bioactive constituents of Aurantii Fructus Immaturus. Yakugaku Zasshi 116: 244-250.
27. Sendra JM, Navarro JL and Lzquierdo L (1988) C18 solid-phase isolation and high-performance liquid chromatography/ultraviolet diode array determination of fully methoxylated flavones in citrus juices. J Chromatogr Sci 26:443-448.
28. Siess M-H, Bon AML and Suschetet M (1992) Dietary modification of drug-metabolizing enzyme activities: Dose-response effect of flavonoids. J Toxicol Environ Health 35:141-152.
29. Siess M-H, Guillermic M, Le Bon AM and Suschetet M (1989) Induction of monooxygenase and transferase activities in rat by dietary administration of flavonoids. Xenobiotica 19:1379-1386.
30. Swift LJ (1967) TLC-spectrophotometric analysis for neutral fraction flavones in orange peel juice. J Agric Food Chem 15:99.
31. Takanaga H, Ohnishi A, Matsuo H and Sawada Y (1998) Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit juice components in Caco-2 cells. Biol Pharm Bull 21:1062-1066.
32. Tamai I and Safa AR (1990) Competitive interaction of cyclosporins with the Vinca alkaloids-binding sites of P-glycoprotein in multidrug-resistant cells. J Biol Chem 265:16509-16513.
33. Tanigawara Y, Okumura N, Hirai M, Yasuhara M, Ueda K, Kioka N, Komano T and Hori R (1992) Transport of digitoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1). J Pharmacol Exp Ther 263:840-845.
34. Tseng KF (1938) Nobiletin. Part I., an oil extracted by cold methyl alcohol from Citrus nobilis, Lour, affords nobiletin, a hexamethoxyflavone containing a veratryl nucleus. Chem Soc 1003-1004.
35. Ueda K, Okumura N, Hirai M, Tanigawara Y, Tohru S, Kioka N, Komano T and Hori R (1992) Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. J Biol Chem 267:24248-24252.
36. Veldhuis MK, Swift LJ and Scott WC (1970) Fully-methoxylated flavones in Florida orange juice. J Agric Food Chem 18:590-592.
37. Verma AK, Johnson JA, Gould MN and Tanner MA (1988) Inhibition of 7,12-dimethylbenz(a)anthracene and N-nitrosomethylurea induced rat mammary cancer by dietary flavonol quercetin. Cancer Res 48:5754-5788.
38. Wacher VJ, Wu C-Y and Benet LZ (1995) Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: Implications for drug delivery and activity in cancer chemotherapy. Mol Carcinog 13:129-134.